Neurology and Neurosurgery - Global Neurology Academy

Episodes 65-80 of 351

Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Global Neurology Academy
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
- Glenn Wylie, DPhil
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiers
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
- Natalie Bareis, PhD, LMSW
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiers
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
- Natalie Bareis, PhD, LMSW
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
NeuroFrontiers
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
NeuroFrontiers
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
- Charles Turck, PharmD, BCPS, BCCCP
- Hank Mayer, MD
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiers
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
NeuroFrontiers
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Global Neurology Academy
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
- Steven Paul, MD
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiers
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
- Steven Paul, MD
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
NeuroFrontiers
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
- Maxwell H. Levy, MD
Navigating Myasthenia Gravis in Adolescents and Young Adults
Navigating Myasthenia Gravis in Adolescents and Young Adults
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
- Jonathan Strober, MD
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
Neurology and Neurosurgery
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
- Desiree Matthews, PMHNP-BC
Spotting the Signs: Early Identification and Management of Schizophrenia
Spotting the Signs: Early Identification and Management of Schizophrenia
Neurology and Neurosurgery
Spotting the Signs: Early Identification and Management of Schizophrenia
- Desiree Matthews, PMHNP-BC
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
- Gil I. Wolfe MD, FAAN
Challenges in DMD: Understanding the Height Factor
Challenges in DMD: Understanding the Height Factor
NeuroFrontiers
Challenges in DMD: Understanding the Height Factor
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
MinuteCE®
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit

5/10